Home » Newsletters » BioWorld Science

BioWorld Science

May 24, 2001

View Archived Issues

Delta Pharmaceuticals reports name change

Pharmacological profile of Ono-6818, an orally active HNE inhibitor, discussed at ATS meeting

Tripep provides update on lead drug candidate GPG

Viozan produces rapid and sustained activation of D2 receptors and beta2-adrenoceptors

Prostanoid receptor agonist protects against warm ischemia-reperfusion injury in rat kidneys

Company Profile: Apovia

Bimosiamose blocks kidney allograft rejection and is synergistic with other agents

Sepracor seeks FDA approval to evaluate new anxiolytic in humans

Ergo Science looking to sell or license Ergoset property rights

Posttranscriptional TNF inhibitor advances towards clinical trials for IBD

Femara approved in Canada as first-line treatment for advanced breast cancer

ID Biomedical begins clinical evaluation of intranasal influenza vaccine

Curcumin may have additional potential in acute pancreatitis

Hybridon completes sale of remaining shares in MethylGene

Development and commercialization rights to ISIS-113715 licensed by Merck

Dual antiinflammatory and antiproliferative effects reported for sPLA2 inhibitor

Dynavax initiates two new phase II/III trials for ragweed allergy treatment

Company Profile: EluSys Therapeutics

First patent for oral gene delivery owned by Genteric

Atherosclerosis inhibited by anti-MCP-1 gene therapy

Peptides based on Mcep sequence and use in tuberculosis vaccines

Ergoline derivatives synthesized at Novartis useful in depression, anxiety, etc.

Orally active, nontoxic antimicrobial agents in the Aventis pipeline

Merck describes new integrin receptor antagonists and therapeutic use thereof

Kissei researchers identify potential new treatments for diabetes and related disorders

Erythromycin derivatives with potent activity against staphylococci and streptococci

New serotonergic agents from BASF covered by U.S. patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...